4.2 Article

Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro

Journal

STEM CELL RESEARCH
Volume 19, Issue -, Pages 128-138

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.scr.2017.01.007

Keywords

iPS cell-derived neural stem/progenitor cells HLA; Mixed lymphocyte reaction; Immunomodulatory function

Funding

  1. Research Center Network for Realization of Regenerative Medicine by the Japan Science and Technology Agency (JST)
  2. Japan Agency for Medical Research and Development (AMED) [16bm0204001h0004]
  3. General Insurance Association of Japan [15-2B-13]
  4. [15K10422]

Ask authors/readers for more resources

To achieve the goal of a first-in-human trial for human induced pluripotent stemcell (hiPSC)-based transplantation for the treatment of various diseases, allogeneic human leukocyte antigen (HLA)-matched hiPSC cell banks represent a realistic tool from the perspective of quality control and cost performance. Furthermore, considering the limited therapeutic time-window for acute injuries, including neurotraumatic injuries, an hiPSC cell bank is of potential interest. However, due to the relatively immunoprivileged environment of the central nervous system, it is unclear whether HLA matching is required in hiPSC-derived neural stem/progenitor cell (hiPSC-NS/PC) transplantation for the treatment of neurodegenerative diseases and neurotraumatic injuries. In this study, we evaluated the significance of HLA matching in hiPSC-NS/PC transplantation by performing modified mixed lymphocyte reaction (MLR) assays with hiPSC-NS/PCs. Compared to fetus-derived NS/PCs, the expression levels of human leukocyte antigen-antigen D related (HLA-DR) and co-stimulatory molecules on hiPSC-NS/PCs were significantly low, even with the addition of tumor necrosis factor-a (TNF alpha) and/or interferon-gamma (IFN gamma) to mimic the inflammatory environment surrounding transplanted hiPSC-NS/PCs in injured tissues. Interestingly, both the allogeneic HLA-matched and the HLA-mismatched responses were similarly low in the modified MLR assay. Furthermore, the autologous response was also similar to the allogeneic response. hiPSC-NS/PCs suppressed the proliferative responses of allogeneic HLA-mismatched peripheral blood mononuclear cells (PBMCs) in a dose-dependent manner. Thus, the low antigen-presenting function and immunosuppressive effects of hiPSC-NS/PCs result in a depressed immune response, even in an allogeneic HLA-mismatched setting. It is crucial to verify whether these in vitro results are reproducible in a clinical setting. (C) 2017 The Authors. Published by Elsevier B. V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available